MX342183B - Suspension oftalmica para uso ocular. - Google Patents

Suspension oftalmica para uso ocular.

Info

Publication number
MX342183B
MX342183B MX2014000927A MX2014000927A MX342183B MX 342183 B MX342183 B MX 342183B MX 2014000927 A MX2014000927 A MX 2014000927A MX 2014000927 A MX2014000927 A MX 2014000927A MX 342183 B MX342183 B MX 342183B
Authority
MX
Mexico
Prior art keywords
ophthalmic suspension
ocular use
ophthalmic
surgical
ocular
Prior art date
Application number
MX2014000927A
Other languages
English (en)
Inventor
Raman Thyaga Rajan Kothanda
Original Assignee
Allergan Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Allergan Inc filed Critical Allergan Inc
Publication of MX342183B publication Critical patent/MX342183B/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Ophthalmology & Optometry (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Composiciones farmacéuticas oftálmicas tópicas de gatifloxacina y prednisolona para la prevención y tratamiento de infecciones bacterianas oftálmicas y condiciones inflamatorias asociadas con cirugías oculares pre-quirúrgicas y/o post-quirúrgicas.
MX2014000927A 2008-09-09 2008-11-13 Suspension oftalmica para uso ocular. MX342183B (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US9545208P 2008-09-09 2008-09-09

Publications (1)

Publication Number Publication Date
MX342183B true MX342183B (es) 2016-09-20

Family

ID=41799806

Family Applications (2)

Application Number Title Priority Date Filing Date
MX2014000927A MX342183B (es) 2008-09-09 2008-11-13 Suspension oftalmica para uso ocular.
MX2008014515A MX2008014515A (es) 2008-09-09 2008-11-13 Suspension oftalmica para uso ocular.

Family Applications After (1)

Application Number Title Priority Date Filing Date
MX2008014515A MX2008014515A (es) 2008-09-09 2008-11-13 Suspension oftalmica para uso ocular.

Country Status (3)

Country Link
US (4) US20100063017A1 (es)
BR (1) BRPI0900723B1 (es)
MX (2) MX342183B (es)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2014138425A1 (en) * 2013-03-08 2014-09-12 Allergan, Inc. Cyclosporine a-steroid conjugates
CN105073140A (zh) 2013-03-08 2015-11-18 阿勒根公司 与类固醇药物直接键联的抗生素缀合物
MX2015011847A (es) * 2013-03-08 2016-01-08 Allergan Inc Conjugados antibioticos vinculados con farmacos esteorides.
JP2016516761A (ja) * 2013-04-09 2016-06-09 クレスセット バイオモレキュラー ディスカバリー リミテッド 炎症性眼疾患の局所治療
US20180318319A1 (en) 2017-05-04 2018-11-08 Ocular Science, Inc. Compositions and Methods for Treating Eyes and Methods of Preparation
CA3119363A1 (en) * 2018-12-04 2020-06-11 Harrow Ip, Llc Pharmaceutical compositions for intraocular administration and methods for fabricating thereof
US11071724B2 (en) 2019-05-17 2021-07-27 Ocular Science, Inc. Compositions and methods for treating presbyopia
US12102632B2 (en) 2020-08-26 2024-10-01 Somerset Therapeutics, Llc Quinolone dispersions
US11510930B2 (en) 2020-08-26 2022-11-29 Somerset Therapeutics, Llc Gatifloxacin, prednisolone, and bromfenac compositions and methods
US11523987B2 (en) 2020-08-26 2022-12-13 Somerset Therapeutics, Llc Trimcinolone and moxifloxacin methods
US11382910B2 (en) 2020-08-26 2022-07-12 Somerset Therapeutics, Llc. Loteprednol and moxifloxacin compositions and methods

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050085446A1 (en) * 2003-04-14 2005-04-21 Babu M.K. M. Fluoroquinolone formulations and methods of making and using the same

Also Published As

Publication number Publication date
US20100063017A1 (en) 2010-03-11
US20110294768A1 (en) 2011-12-01
US20130338126A1 (en) 2013-12-19
BRPI0900723A2 (pt) 2010-05-18
BRPI0900723B1 (pt) 2022-06-14
US20140213561A1 (en) 2014-07-31
MX2008014515A (es) 2010-04-29

Similar Documents

Publication Publication Date Title
MX2008014515A (es) Suspension oftalmica para uso ocular.
MY171920A (en) Prevention and treatment of ocular conditions
MY153669A (en) Ocular allergy treatments field of the invention
HK1199725A1 (en) Heterocyclic compounds and uses thereof
HK1198443A1 (en) Heterocyclic compounds and uses thereof
AU2012243329A8 (en) 5-substituted iminothiazines and their mono-and dioxides as BACE inhibitors,compositions,and their use
WO2012047587A3 (en) Mdm2 inhibitors for treatment of ocular conditions
EP4606434A3 (en) Deuterated derivatives of ruxolitinib
WO2014028591A3 (en) N-ALKYLATED INDOLE AND INDAZOLE COMPOUNDS AS RORgammaT INHIBITORS AND USES THEREOF
WO2014028931A3 (en) Compounds and methods for treating mammalian gastrointestinal microbial infections
MX2012000136A (es) Composiciones que comprenden finafloxacina y metodos para tratar infecciones oftalmicas, oticas, o nasales.
MX2013001204A (es) Compuesto para el tratamiento/prevencion de enfermedades inflamatorias oculares.
MX2009010407A (es) Derivados fluorados de deferiprona.
MY160018A (en) 4-[2-[[5-methyl-1-(2-naphtalenyl)-1h-pyrazol-3-yl]oxy]ethyl]morpholine salts
PL2257275T3 (pl) Kompozycje trometaminy ketorolaku do leczenia lub zapobiegania bólu ocznego
MY188453A (en) Antimicrobial compositions
IN2014DN06869A (es)
WO2012107890A3 (en) Crystal forms of lurasidone chlorhydrate
MX372951B (es) Composiciones y metodos de tratamiento que comprenden ceftarolina.
PH12012501271A1 (en) Topical ophthalmic peptide formulation
IN2012DN06061A (es)
BRPI0811223A2 (pt) Métodos para modular uma inflamação em um paciente, e para tratar, controlar, reduzir ou melhorar uma infecção ocular ou oftálmica e uma sequela inflamatória da mesma, uso de uma fluoroquinolona, e, composição farmacêutica.
MX2012004282A (es) Composiciones farmaceuticas.
UA94938C2 (ru) Офтальмическая композиция для лечения клинических симптомов глазной аллергии, которая содержит алкафтадин или его производное (варианты)
PH12015501230A1 (en) Finafloxacin suspension compositions